Clinical Trial Update: Azacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 study of azacitidine in patients with newly diagnosed or secondary acute myeloid leukemia who are unsuitable for intensive chemotherapy has been complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)

Snippet

Sponsor: Swiss Cancer Institute | Conditions: Leukemia | Phase 2 | Status: COMPLETED